Strazeneca Covid-19 Vaccine And Covishield: Risk Of Thrombosis With Thrombocytopenia
Recall Summary AstraZeneca's COVID-19 vaccine and COVISHIELD have been recalled in Canada due to a risk of thrombosis with thrombocytopenia, a condition involving blood clots and low platelet counts. The recall affects vaccine supplies distributed across Canada. This recall is related to product safety concerns identified with the vaccine.
- Reason
- COVID - Product safety
- Category
- drug recall
- Country
- Canada
- Agency
- HC-DRUGS
- Recall date
- 2021-03-24
- Status
- Ongoing
- Distribution
- Canada-wide
Official recall notice from HC-DRUGS
Recall details on Nibble Recalls: https://trynibble.app/recalls/9b34fc44-5a87-4041-ba16-1612ca49b44b